These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28111831)

  • 21. Ocrelizumab reduces cortical and deep grey matter loss compared to the S1P-receptor modulator in multiple sclerosis.
    Bajrami A; Tamanti A; Peloso A; Ziccardi S; Guandalini M; Calderone M; Castellaro M; Pizzini FB; Montemezzi S; Marastoni D; Calabrese M
    J Neurol; 2024 May; 271(5):2149-2158. PubMed ID: 38289534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between episodic memory and volume of the brain regions of two functional cortical memory systems in multiple sclerosis.
    Aladro Y; López-Alvarez L; Sánchez-Reyes JM; Hernández-Tamames JA; Melero H; Rubio-Fernández S; Thuissard I; Cerezo-García M
    J Neurol; 2018 Oct; 265(10):2182-2189. PubMed ID: 29995292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo detection of connectivity between cortical and white matter lesions in early MS.
    Tillema JM; Weigand SD; Mandrekar J; Shu Y; Lucchinetti CF; Pirko I; Port JD
    Mult Scler; 2017 Jun; 23(7):973-981. PubMed ID: 27698248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain atrophy and physical disability in primary progressive multiple sclerosis: A volumetric study.
    Galego O; Gouveia A; Batista S; Moura C; Machado E
    Neuroradiol J; 2015 Jun; 28(3):354-8. PubMed ID: 26246109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cortical lesion load associates with progression of disability in multiple sclerosis.
    Calabrese M; Poretto V; Favaretto A; Alessio S; Bernardi V; Romualdi C; Rinaldi F; Perini P; Gallo P
    Brain; 2012 Oct; 135(Pt 10):2952-61. PubMed ID: 23065788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Deep Gray Matter Damage With Cortical and Spinal Cord Degeneration in Primary Progressive Multiple Sclerosis.
    Ruggieri S; Petracca M; Miller A; Krieger S; Ghassemi R; Bencosme Y; Riley C; Howard J; Lublin F; Inglese M
    JAMA Neurol; 2015 Dec; 72(12):1466-74. PubMed ID: 26457955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased cortical grey matter lesion detection in multiple sclerosis with 7 T MRI: a post-mortem verification study.
    Kilsdonk ID; Jonkman LE; Klaver R; van Veluw SJ; Zwanenburg JJ; Kuijer JP; Pouwels PJ; Twisk JW; Wattjes MP; Luijten PR; Barkhof F; Geurts JJ
    Brain; 2016 May; 139(Pt 5):1472-81. PubMed ID: 26956422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Staging of cortical and deep grey matter functional connectivity changes in multiple sclerosis.
    Meijer KA; Eijlers AJC; Geurts JJG; Schoonheim MM
    J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):205-210. PubMed ID: 28986469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cortical relapses in multiple sclerosis.
    Puthenparampil M; Poggiali D; Causin F; Rolma G; Rinaldi F; Perini P; Gallo P
    Mult Scler; 2016 Aug; 22(9):1184-91. PubMed ID: 25791367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced functional connectivity between ventromedial prefrontal cortex and insula relates to longer corrected QT interval in HIV+ and HIV- individuals.
    McIntosh RC; Chow DC; Lum CJ; Hidalgo M; Shikuma CM; Kallianpur KJ
    Clin Neurophysiol; 2017 Oct; 128(10):1839-1850. PubMed ID: 28826014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis.
    Deppe M; Marinell J; Krämer J; Duning T; Ruck T; Simon OJ; Zipp F; Wiendl H; Meuth SG
    Neuroimage Clin; 2014; 6():475-87. PubMed ID: 25610761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal quantitative MRI assessment of cortical damage in multiple sclerosis: A pilot study.
    Gracien RM; Reitz SC; Hof SM; Fleischer V; Droby A; Wahl M; Steinmetz H; Groppa S; Deichmann R; Klein JC
    J Magn Reson Imaging; 2017 Nov; 46(5):1485-1490. PubMed ID: 28240801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intra- and interscanner variability of magnetic resonance imaging based volumetry in multiple sclerosis.
    Biberacher V; Schmidt P; Keshavan A; Boucard CC; Righart R; Sämann P; Preibisch C; Fröbel D; Aly L; Hemmer B; Zimmer C; Henry RG; Mühlau M
    Neuroimage; 2016 Nov; 142():188-197. PubMed ID: 27431758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epilepsy in multiple sclerosis: The role of temporal lobe damage.
    Calabrese M; Castellaro M; Bertoldo A; De Luca A; Pizzini FB; Ricciardi GK; Pitteri M; Zimatore S; Magliozzi R; Benedetti MD; Manganotti P; Montemezzi S; Reynolds R; Gajofatto A; Monaco S
    Mult Scler; 2017 Mar; 23(3):473-482. PubMed ID: 27260699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of lesional and extra-lesional cortical grey matter in relapsing-remitting and secondary progressive multiple sclerosis: A magnetisation transfer and diffusion tensor imaging study.
    Yaldizli Ö; Pardini M; Sethi V; Muhlert N; Liu Z; Tozer DJ; Samson RS; Wheeler-Kingshott CA; Yousry TA; Miller DH; Chard DT
    Mult Scler; 2016 Feb; 22(2):150-9. PubMed ID: 26014608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association of cognitive impairment with gray matter atrophy and cortical lesion load in clinically isolated syndrome.
    Diker S; Has AC; Kurne A; Göçmen R; Oğuz KK; Karabudak R
    Mult Scler Relat Disord; 2016 Nov; 10():14-21. PubMed ID: 27919482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identical lesion morphology in primary progressive and relapsing-remitting MS--an ultrahigh field MRI study.
    Kuchling J; Ramien C; Bozin I; Dörr J; Harms L; Rosche B; Niendorf T; Paul F; Sinnecker T; Wuerfel J
    Mult Scler; 2014 Dec; 20(14):1866-71. PubMed ID: 24781284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between the corpus callosum index and brain atrophy, lesion load, and cognitive dysfunction in multiple sclerosis.
    Gonçalves LI; Dos Passos GR; Conzatti LP; Burger JLP; Tomasi GH; Zandoná MÉ; Azambuja LS; Gomes I; Franco A; Sato DK; Becker J
    Mult Scler Relat Disord; 2018 Feb; 20():154-158. PubMed ID: 29414290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients.
    Zivadinov R; Uher T; Hagemeier J; Vaneckova M; Ramasamy DP; Tyblova M; Bergsland N; Seidl Z; Dwyer MG; Krasensky J; Havrdova E; Horakova D
    Mult Scler; 2016 Nov; 22(13):1709-1718. PubMed ID: 26883943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
    Sacco R; Bisecco A; Corbo D; Della Corte M; d'Ambrosio A; Docimo R; Gallo A; Esposito F; Esposito S; Cirillo M; Lavorgna L; Tedeschi G; Bonavita S
    J Neurol; 2015 Jul; 262(7):1691-7. PubMed ID: 25957638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.